Selected research
Industry Research
Integrin Alpha 4 Industry Research Report 2026
Market perspective
The global Integrin Alpha 4 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Integrin Alpha 4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Integrin Alpha 4 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Integrin Alpha 4 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Integrin Alpha 4 include Takeda Pharmaceutical Co Ltd, Viriom Inc, Protagonist Therapeutics Inc, Morphic Therapeutic Inc, Immunwork Inc, EA Pharma Co Ltd, Daiichi Sankyo Co Ltd, BioMAS Ltd and Biogen Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Integrin Alpha 4 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Integrin Alpha 4 Market by Company
Takeda Pharmaceutical Co Ltd
Viriom Inc
Protagonist Therapeutics Inc
Morphic Therapeutic Inc
Immunwork Inc
EA Pharma Co Ltd
Daiichi Sankyo Co Ltd
BioMAS Ltd
Biogen Inc
Antisense Therapeutics Ltd
Amgen Inc
Integrin Alpha 4 Segment by Type
ATL-1102
Carotegrast
ET-3764
TE-5232
Others
Integrin Alpha 4 Segment by Application
Acute Ischemic Stroke
Melanoma
Celiac Disease
Multiple Sclerosis
Epilepsy
Other
Integrin Alpha 4 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha 4.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Integrin Alpha 4 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Integrin Alpha 4 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Integrin Alpha 4 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ATL-1102
- Carotegrast
- ET-3764
- TE-5232
- Others
Applications
- Acute Ischemic Stroke
- Melanoma
- Celiac Disease
- Multiple Sclerosis
- Epilepsy
- Other
Companies covered
- Takeda Pharmaceutical Co Ltd
- Viriom Inc
- Protagonist Therapeutics Inc
- Morphic Therapeutic Inc
- Immunwork Inc
- EA Pharma Co Ltd
- Daiichi Sankyo Co Ltd
- BioMAS Ltd
- Biogen Inc
- Antisense Therapeutics Ltd
- Amgen Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Integrin Alpha 4 Market Size (2021-2032)
- 2.2.2 Global Integrin Alpha 4 Sales (2021-2032)
- 2.2.3 Global Integrin Alpha 4 Market Average Price (2021-2032)
- 2.3 Integrin Alpha 4 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ATL-1102
- 2.3.3 Carotegrast
- 2.3.4 ET-3764
- 2.3.5 TE-5232
- 2.3.6 Others
- 2.4 Integrin Alpha 4 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Acute Ischemic Stroke
- 2.4.3 Melanoma
- 2.4.4 Celiac Disease
- 2.4.5 Multiple Sclerosis
- 2.4.6 Epilepsy
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Integrin Alpha 4 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Integrin Alpha 4 Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Integrin Alpha 4 Revenue of Manufacturers (2021-2026)
- 3.4 Global Integrin Alpha 4 Average Price by Manufacturers (2021-2026)
- 3.5 Global Integrin Alpha 4 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Integrin Alpha 4, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Integrin Alpha 4, Product Type & Application
- 3.8 Global Manufacturers of Integrin Alpha 4, Established Date
- 3.9 Global Integrin Alpha 4 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda Pharmaceutical Co Ltd
- 4.1.1 Takeda Pharmaceutical Co Ltd Company Information
- 4.1.2 Takeda Pharmaceutical Co Ltd Business Overview
- 4.1.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolio
- 4.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
- 4.2 Viriom Inc
- 4.2.1 Viriom Inc Company Information
- 4.2.2 Viriom Inc Business Overview
- 4.2.3 Viriom Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Viriom Inc Integrin Alpha 4 Product Portfolio
- 4.2.5 Viriom Inc Recent Developments
- 4.3 Protagonist Therapeutics Inc
- 4.3.1 Protagonist Therapeutics Inc Company Information
- 4.3.2 Protagonist Therapeutics Inc Business Overview
- 4.3.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolio
- 4.3.5 Protagonist Therapeutics Inc Recent Developments
- 4.4 Morphic Therapeutic Inc
- 4.4.1 Morphic Therapeutic Inc Company Information
- 4.4.2 Morphic Therapeutic Inc Business Overview
- 4.4.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolio
- 4.4.5 Morphic Therapeutic Inc Recent Developments
- 4.5 Immunwork Inc
- 4.5.1 Immunwork Inc Company Information
- 4.5.2 Immunwork Inc Business Overview
- 4.5.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Immunwork Inc Integrin Alpha 4 Product Portfolio
- 4.5.5 Immunwork Inc Recent Developments
- 4.6 EA Pharma Co Ltd
- 4.6.1 EA Pharma Co Ltd Company Information
- 4.6.2 EA Pharma Co Ltd Business Overview
- 4.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolio
- 4.6.5 EA Pharma Co Ltd Recent Developments
- 4.7 Daiichi Sankyo Co Ltd
- 4.7.1 Daiichi Sankyo Co Ltd Company Information
- 4.7.2 Daiichi Sankyo Co Ltd Business Overview
- 4.7.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolio
- 4.7.5 Daiichi Sankyo Co Ltd Recent Developments
- 4.8 BioMAS Ltd
- 4.8.1 BioMAS Ltd Company Information
- 4.8.2 BioMAS Ltd Business Overview
- 4.8.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BioMAS Ltd Integrin Alpha 4 Product Portfolio
- 4.8.5 BioMAS Ltd Recent Developments
- 4.9 Biogen Inc
- 4.9.1 Biogen Inc Company Information
- 4.9.2 Biogen Inc Business Overview
- 4.9.3 Biogen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Biogen Inc Integrin Alpha 4 Product Portfolio
- 4.9.5 Biogen Inc Recent Developments
- 4.10 Antisense Therapeutics Ltd
- 4.10.1 Antisense Therapeutics Ltd Company Information
- 4.10.2 Antisense Therapeutics Ltd Business Overview
- 4.10.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolio
- 4.10.5 Antisense Therapeutics Ltd Recent Developments
- 4.11 Amgen Inc
- 4.11.1 Amgen Inc Company Information
- 4.11.2 Amgen Inc Business Overview
- 4.11.3 Amgen Inc Integrin Alpha 4 Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Amgen Inc Integrin Alpha 4 Product Portfolio
- 4.11.5 Amgen Inc Recent Developments
5 Global Integrin Alpha 4 Market Scenario by Region
- 5.1 Global Integrin Alpha 4 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Integrin Alpha 4 Sales by Region: 2021-2032
- 5.2.1 Global Integrin Alpha 4 Sales by Region: 2021-2026
- 5.2.2 Global Integrin Alpha 4 Sales by Region: 2027-2032
- 5.3 Global Integrin Alpha 4 Revenue by Region: 2021-2032
- 5.3.1 Global Integrin Alpha 4 Revenue by Region: 2021-2026
- 5.3.2 Global Integrin Alpha 4 Revenue by Region: 2027-2032
- 5.4 North America Integrin Alpha 4 Market Facts & Figures by Country
- 5.4.1 North America Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Integrin Alpha 4 Sales by Country (2021-2032)
- 5.4.3 North America Integrin Alpha 4 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Integrin Alpha 4 Market Facts & Figures by Country
- 5.5.1 Europe Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Integrin Alpha 4 Sales by Country (2021-2032)
- 5.5.3 Europe Integrin Alpha 4 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Integrin Alpha 4 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Integrin Alpha 4 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Integrin Alpha 4 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Integrin Alpha 4 Market Facts & Figures by Country
- 5.7.1 South America Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Integrin Alpha 4 Sales by Country (2021-2032)
- 5.7.3 South America Integrin Alpha 4 Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Integrin Alpha 4 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Integrin Alpha 4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Integrin Alpha 4 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Integrin Alpha 4 Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Integrin Alpha 4 Sales by Type (2021-2032)
- 6.1.1 Global Integrin Alpha 4 Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Integrin Alpha 4 Sales Market Share by Type (2021-2032)
- 6.2 Global Integrin Alpha 4 Revenue by Type (2021-2032)
- 6.2.1 Global Integrin Alpha 4 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Integrin Alpha 4 Revenue Market Share by Type (2021-2032)
- 6.3 Global Integrin Alpha 4 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Integrin Alpha 4 Sales by Application (2021-2032)
- 7.1.1 Global Integrin Alpha 4 Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Integrin Alpha 4 Sales Market Share by Application (2021-2032)
- 7.2 Global Integrin Alpha 4 Revenue by Application (2021-2032)
- 7.2.1 Global Integrin Alpha 4 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Integrin Alpha 4 Revenue Market Share by Application (2021-2032)
- 7.3 Global Integrin Alpha 4 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Integrin Alpha 4 Value Chain Analysis
- 8.1.1 Integrin Alpha 4 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Integrin Alpha 4 Production Mode & Process
- 8.2 Integrin Alpha 4 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Integrin Alpha 4 Distributors
- 8.2.3 Integrin Alpha 4 Customers
9 Global Integrin Alpha 4 Analyzing Market Dynamics
- 9.1 Integrin Alpha 4 Industry Trends
- 9.2 Integrin Alpha 4 Industry Drivers
- 9.3 Integrin Alpha 4 Industry Opportunities and Challenges
- 9.4 Integrin Alpha 4 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst